New Insights on Using Oral Semaglutide versus Dapagliflozin in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease
暂无分享，去创建一个
A. Sîngeap | A. Trifan | T. Cuciureanu | S. Chiriac | I. Gîrleanu | C. Sfarti | L. Huiban | C. Muzica | S. Zenovia | R. Nastasa | O. Petrea | A. Rotaru | R. Stafie | H. Minea | C. Stanciu | E. Stratina | Oana Vlad | Camelia Cojocariu